Expertise in
6
conditions

Andreia C. De Melo

Rio De Janeiro, RJ, BR 
Expertise in
6
conditions
Rio De Janeiro, RJ, BR 

Overview

Andreia De Melo practices practicing medicine in Rio De Janeiro, Brazil.

Ms. De Melo is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Acinic Cell Carcinoma of Salivary Glands, Gestational Trophoblastic Disease, Glossectomy, and Salpingo-Oophorectomy.

She is actively involved in clinical research, co-authoring 135 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Rio De Janeiro, RJ, Brazil
Other Locations
Cavalcanti, RJ 20231050, Brazil
Brazil
Sao Paulo, SP, Brazil
Fatima, RJ 20231050, Brazil
Eva, RR, Brazil
Santo Cristo, RJ, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multicenter Phase 3, Double-Blind, Placebo-Controlled Study Comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin- Oregovomab) vs Chemotherapy (Paclitaxel-Carboplatin- Placebo) in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma
A Multicenter Phase 3, Double-Blind, Placebo-Controlled Study Comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin- Oregovomab) vs Chemotherapy (Paclitaxel-Carboplatin- Placebo) in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: April 01, 2026
Intervention Type: Biological, Drug
Study Drugs: Oregovomab, Paclitaxel, Carboplatin
Study Phase: Phase 3
A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (Anti-PD-1) as a Monotherapy or Combination Therapy With AGEN1884 (Anti- CTLA4) or With Placebo in Women With Recurrent Cervical Cancer (Second Line) - RaPiDS
A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (Anti-PD-1) as a Monotherapy or Combination Therapy With AGEN1884 (Anti- CTLA4) or With Placebo in Women With Recurrent Cervical Cancer (Second Line) - RaPiDS
Enrollment Status: Terminated
Publish Date: March 27, 2026
Intervention Type: Drug
Study Drugs: AGEN-2034 PD-1 Antibody, AGEN-1884 CTLA4 Antibody
Study Phase: Phase 2
A Phase 1/2, Open-Label, Multiple Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN2034 in Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion to Second Line Cervical Cancer
A Phase 1/2, Open-Label, Multiple Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN2034 in Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion to Second Line Cervical Cancer
Enrollment Status: Completed
Publish Date: July 30, 2025
Intervention Type: Drug
Study Drug: AGEN-2034 PD-1 Antibody
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

135 Total Publications

Response to comments by Muskaan and colleagues on the article "In vivo dosimetry in patients undergoing radiotherapy for head and neck cancer using an intraoral stent: a prospective cohort".
Response to comments by Muskaan and colleagues on the article "In vivo dosimetry in patients undergoing radiotherapy for head and neck cancer using an intraoral stent: a prospective cohort".
Journal: Oral surgery, oral medicine, oral pathology and oral radiology
Published: June 17, 2026

Frequently Asked Questions about Andreia C. De Melo

Is Andreia C. De Melo a top-rated expert for Cervical Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Andreia C. De Melo is classified as an Distinguished expert for Cervical Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Andreia C. De Melo participate in research or clinical trials?

Yes. Andreia C. De Melo has published 135 articles and abstracts on conditions like Cervical Cancer. You can view a list of Andreia C. De Melo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. De Melo's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile